Articles
Feature: Australian Synchrotron transforms proteomics
Melbourne X-ray crystallographer, Tom Caradoc-Davies, needed only one hour on the Australian Synchrotron’s beamline to obtain the high-resolution diffraction data that revealed the structure of a key component of bacterial pili. [ + ]
New learning pathway could lead to Alzheimer’s cure
Australian and US researchers have shown that the brain uses a different physiological pathway to form memories for the first time than it uses for subsequent learning of similar information. [ + ]
Breakthrough for basal breast cancer
Australian researchers have used a novel technique for protein analysis to partly unravel the mystery of basal breast cancer. [ + ]
Protocols for converting cells to serum-free culture
Instructions for use are provided in this article for protocols for converting cells to serum-free culture.
[ + ]Instructions for Cryopreservation
Cryopreservation may compromise cell quality and performance. Performance of the cells CANNOT be guaranteed after cryopreservation.
[ + ]Australian fingerprint technology aids forensic investigators
The University of Technology Sydney is commercialising a rapid technique that can be used to develop ‘invisible’ fingerprints on porous surfaces such as paper, cloth and wood.
[ + ]Looking for secrets to drug addiction
A US study aims to look for dependency biomarkers in the blood that will indicate current and past use and abuse of illicit drugs. On top of that the study would like to find indicators identifying people who may be prone to abuse drugs in the future.
[ + ]APAC enjoying surge in VC funding
Venture capital activity is growing strongly throughout the Asia pacific biomedical and biotech sectors at the same time as the US and Europe suffer sharp declines, according to industry database MedTRACK. [ + ]
Ovarian cancer breakthrough
A group of international scientists has identified a handful of important new genetic variants indicating increased risk of ovarian cancer, which also reveal the genetic similarities between it and breast cancer. [ + ]
Could microRNAs prove to be cancer’s ultimate Achilles heel?
It’s apparent pointlessness in the grand scheme of human biology earned it the label of ‘Junk DNA’. However, in a study published this week in Nature Medicine, researchers have provided the most compelling evidence yet that microRNA is anything but superfluous, and may in fact help to unravel the mysteries of cancer as well as other diseases. [ + ]
Market report: Healthcare index up as wider market falls
In a reversal of last week's pattern, the S&P ASX/200 Healthcare Index put on a strong showing today to finish the week in positive territory while the wider market fell to snap a three week winning streak. [ + ]
Protein identified as central to immune system
Researchers from the Walter and Eliza Hall Institute (WEHI) have identified the one protein without which the body is unable to regulate immune cells. [ + ]
J&J to buy Crucell for US$2.29 billion
Johnson & Johnson has offered US$2.29 billion to buy Dutch biotech Crucell NV, the two companies announced this week. [ + ]
Wollongong Uni researchers awarded US patent
Researchers from the University of Wollongong’s (UOW) Schools of Chemistry and Health Sciences have been awarded a US patent for their novel method of characterising lipid molecules. [ + ]